Navigation Links
Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
Date:5/12/2008

ncome margins above 20% in fiscal 2009. For fiscal 2009, the Company anticipates revenue increasing 5% to 10% above the $101 million achieved in fiscal 2008. The Company also expects net income to increase 20% to 30% above the $10.4 million recognized in fiscal 2008. We expect new Zicam product offerings in fiscal 2009 and anticipate initial international sales to begin in Canada."

According to William Hemelt, Executive Vice President and Chief Financial Officer, "We continue to make progress on the product liability front. In April, we reported on a unanimous jury decision in favor of the Company in a trial in California. Together with the eight favorable Daubert decisions, we have now established a strong legal record that affirms our position that allegations linking Zicam Cold Remedy to anosmia lack scientific foundation. Although we incurred higher legal expense for the recent trial, product liability defense costs decreased to $2.5 million (net of $560,000 for insurance reimbursements) for the year ended March 31, 2008, compared to $4.1 million for the twelve months ended March 31, 2007 (net of $1.6 million for insurance reimbursements). We anticipate legal defense costs will be $500,000 to $750,000 per quarter during fiscal 2009."

Mr. Hemelt continued, "Gross margin increased to 67% for the quarter ended March 31, 2008, compared to 63% for the quarter ended March 31, 2007. Fourth quarter gross margin was adversely affected by the recording of an additional $1.1 million to the inventory reserve to account for expiring products and obsolete components. Additionally, gross margin was adversely affected by the recognition of approximately $1.0 million for product returns of expired and discontinued products in excess of our customary return provision. We achieved average gross margins of 66% for fiscal 2008, which was affected by the aforementioned adjustments, and was comparable to 66% in the prior year."

"Fiscal 2008 net income was favorabl
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2008 Financial Results
2. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
4. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
5. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
6. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
7. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
10. CryoCath Announces Fiscal 2008 Second Quarter Results
11. OmniSonics Medical Technologies Announces First Patient Enrolled in SONIC II REGISTRY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... -- Genes may interact with stress to trigger heart disease ... risk occurs in about 13 percent of people, but only ... people reduce their heart disease risk through simple measures such ... Duke University researchers said. The study authors analyzed genetic ... between variations in the EBF1 gene and higher levels of ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, ... roses -- literally -- may face an increased risk of dying ... study of over 3,000 older Americans, researchers found those who were ... more than three times as likely to die in the next ... In fact, anosmia -- the inability to distinguish odors -- was ...
(Date:10/1/2014)... developed a model that could help to predict a ... from their very first psychotic episode. , The model ... symptoms, cognitive abilities, MRI scans of the brain,s structure, ... the lead up to World Mental Health Day (10 ... Professor Bernhard Baune , says the model is a ...
(Date:10/1/2014)... the human eye, the brain of a rat and ... technology, says a QUT leading robotics researcher. , ... says the new study uses new computer algorithms to ... or tunnels. , "This is a very Frankenstein type ... halves of a thing together because we,re taking the ...
(Date:10/1/2014)... encourages people to keep their "eyes on the prize" ... When walking, staying focused on a specific target ahead ... help people walk there faster, psychology researchers have found. ... looking around the environment naturally, offers a new strategy ... less interested in exercise if physical activity seems daunting, ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Predicting the future course of psychotic illness 2Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3
... suffered cardiac death would have their bodies prepared for ... Australian Health Ethics Committee that is working on organ ... patients who are certain to die after experiencing cardiac ... heart, liver lungs and kidneys begin to deteriorate immediately ...
... help Alzheimer's patients interact and communicate with others, finds ... Newcastle General Hospital studied the benefits of dolls after ... from her son, reported the online edition of BBC ... can lose their intellectual, social and emotional abilities over ...
... major public health threat posed by antibiotic-resistant bacteria, ... (UCSD) are launching a new program to develop ... and testing, to clinical trials. ,"UCSD ... necessary expertise to fight this urgent medical problem," ...
... discovered around 1994 which has the ability to perform multi ... other crucial physiological activities. , But the ... out these metabolic activities were not known till date. Now, ... University have identifies the mode in which Leptin carries out ...
... University, Doug Goodin, makes use of satellite imagery to ... //changes on human health and food security. ... types of data, to monitor and predict the spread ... discussed this subject at the workshop, "Contributions of Remote ...
... men for a good 14 years has revealed that regular ... body weight has an impact in cutting down the risks ... co-author of the study, said "Even though erectile problems were ... clear that heart disease and ED share many of the ...
Cached Medicine News:Health News:New UCSD Program to Fight Drug-Resistant Bacteria 2Health News:New UCSD Program to Fight Drug-Resistant Bacteria 3Health News:New UCSD Program to Fight Drug-Resistant Bacteria 4Health News:How Does Leptin Work? 2Health News:Satellite Imagery to monitor the Social Impact Of Geographical Changes 2
(Date:9/30/2014)... 2014  Tasly Pharmaceuticals, Inc., the world,s leader ... today the launch of Deepure. Deepure ... men and women concerned with supporting their overall ... age while helping keep their health care cost ... herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and ...
(Date:9/30/2014)... 30, 2014 Aileron Therapeutics, Inc. - ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - Product ... the Aileron Therapeutics, Inc.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Aileron Therapeutics, ... therapeutics assessment by drug target, mechanism of action ...
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4
... 9 Peptimmune, Inc., a privately,held biotechnology ... peptide copolymer program at both the 17th ... FOCIS 2008 in Boston, MA. The Company ... study involving,healthy, male adult volunteers following SC ...
... juice has ... NEW YORK, June 9 CherryPharm -- a proprietary,all-natural ... of,cherries -- has been shown to improve aspects of sleep, ... This double-blind,placebo controlled clinical trial tested the effectiveness of CherryPharm,in ...
Cached Medicine Technology:Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 2Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings 3CherryPharm First All-Natural Food to Improve Sleep 2
... Disease ELISA kits utilize ... Also included in each ... negative controls, serum diluent, ... Use an ELISA plate ...
... (PCR) technology, the worlds leading nucleic acid ... Roches blood screening assays and other diagnostic ... unique regions of genetic material to be ... to detectable levels) in only a few ...
... Continuing to lead the market in ... WAVE IABP is a whole new first ... optic technology coupled with a physiologically based ... support with unprecedented timing accuracy. Second ...
... worlds first truly automated immunohistochemistry ... a whole new level of ... modularity and ease of operation ... NexES Systems automated technology provides ...
Medicine Products: